2 results
Prazosin for the treatment of Obsessive Compulsive Disorder:
An open label, fixed dose add-on study.
To determine whether the addition of the *1 adrenoreceptor antagonist prazosin to SSRI is useful for patients with OCD who do not respond to SRI monotherapy.
Approved WMOCompleted
The present study aims to initiate the testing of a new, curative, person-directed, approach of patients with burnout, that uses neurofeedback, also called EEG (electroencephalogram)-biofeedback.